2010 Metals in Medicine Gordon Research Conference

描述（由申请人提供）：经常在当地医生办公室发现的广告，描绘了一个寒冷世界中的小孩，文字“这个孩子有药物问题”，记录了今天对抗疾病的非常规方法的需求。事实上，戈登研究会议“医学中的金属：药用无机化学”正是这一事业的先锋。在肿瘤学领域，顺铂和其他铂类药物已经证明了金属药物的成功，其他领域仍在满怀希望地等待类似的发现。然而，随着许多新的方法的研究继续推动过去的成功，如保罗埃利希的抗梅毒剂砷苯那明（萨尔瓦森）。重要的是，研究人员和临床医生需要一个共同的论坛，可以共享信息和策略。为此，必须创造出一个可以孕育新发现的肥沃环境。 医学中的金属戈登研究会议将于2010年6月27日至7月2日在新罕布什尔州普罗克特学院举行。本次会议将有来自不同背景和不同国籍的演讲者进行广泛的演讲。此外，混合将包括高级调查员，以及开始调查员和学生主持人。在这次会议上，将首次从提交的摘要中选出一大部分年轻科学家的演讲，并在实验的基础上为学生和年轻和初出茅庐的科学家提供一个论坛，以学习和发展关键技能，开发新的疾病治疗方法。我们相信，这种新型演示的增加对我们的领域很重要，可以帮助促进伙伴关系和合作以及明天药物和治疗的发展。这样的方法将允许一种格式来更新那些在该地区什么是成功的诊所，以及在疾病的战斗实验室。 在医学戈登会议上，我们有机会汇集一批跨学科的科学家和医生，分享和学习无机化学，生物化学，生物学和医学在临床前的发展，并在实验或医院类型的设置患者的治疗。在这次会议上，我们将涵盖以下七个与健康相关的领域：肿瘤学，诊断/成像，核医学，传染病和神经退行性疾病，代谢紊乱，心血管疾病和衰老。 公共卫生相关性：戈登研究会议金属医学是一个多学科的会议，其中化学家，生物化学家，生物学家，药剂师和临床医生走到一起，学习基础科学和临床工作的最新技术。医学中的金属是一个快速发展的领域，有几种关键药物，如肿瘤学中的顺铂，MRI造影剂，Cardiolyte放射性药物成像剂和纳米科学应用。这些对抗疾病的新颖和非常规方法需要多学科的连接，以验证研究人员在实验室和临床环境中开发所需的结果。会议将在以下七个健康相关领域展示当前的临床实践和发现水平研究：肿瘤学，诊断/成像，核医学，传染病和神经退行性疾病，代谢紊乱，心血管疾病和衰老。

DESCRIPTION (provided by applicant): Advertisements often found in the local physician's office, depicting a small child in a cold world with the text "this child has a drug problem" is documenting how much need there is for unconventional approaches to fight disease today. Indeed, the Gordon Research conference "Metals in Medicine: Medicinal Inorganic Chemistry" is spearheading just this cause. Solidly rooted in the area of oncology where cisplatin and other platinum drugs have documented the success of metal-based drugs, other areas are still hopefully waiting for similar discoveries. However, with many new approaches the search continues fueled by the past successes, such as Paul Ehrlich's anti-syphilitic agent arsphenamine (Salvarsan). Importantly, the researchers and clinicians need a common forum where information and strategies can be shared. To this end the fertile environment upon which discoveries can be born must be created. The Metals in Medicine Gordon Research Conference will be held at Proctor Academy, NH, June 27-July 2nd, 2010. This meeting will feature a broad range of presentations from a diverse group of speakers from different backgrounds and of different Nationalities. In addition, the mix will include senior level investigators, as well as beginning investigators and student presenters. For the first time in this conference a significant fraction of young scientist presentations will be selected from the submitted abstracts and on an experimental basis thus provide a forum for the students and young and beginning scientists to learn and develop key skills to develop new treatments of disease. We believe that the addition of this new type of presentation is important to our area and can help foster partnerships and collaborations and the development of the drug and treatments of tomorrow. Such an approach will allow a format to update those in the area what is successful in the clinic, as well as the laboratory in the battle of diseases. At the Metals in Medicine Gordon Conference we have the opportunity to bring together a group of interdisciplinary scientists and physicians to share and learn from inorganic chemistry, to biochemistry, biology and medicine in preclinical development and to treatment of patients in an experimental or hospital-type setting. At this meeting we will cover the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging. PUBLIC HEALTH RELEVANCE: The Gordon Research Conference Metals in Medicine is a multidisciplinary meeting, in which chemists, biochemists, biologist, pharmacist and clinicians come together to learn the state-of-the-art in both basic sciences and clinical work. Metals in Medicine is a rapidly developing field documented with several key drugs, such as cisplatin in oncology, MRI contrast agents, Cardiolyte radiopharmaceutical imaging agents and nanoscience applications. These novel and unconventional approaches to fighting disease require multidisciplinary connectivity to validate the results needed by researchers to develop in laboratories and clinical settings alike. The meeting will feature both current clinical practices and discovery-level research in the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging.